Dopamine Neuron Stimulating Peptide-11 Protection From Complex 1 Mitochondrial Inhibitors

摘要

The present invention relates to the use of novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)), for treating brain diseases and injuries that result in dopaminergic deficiencies and mitochodrial dysfunction, e.g., reduced complex I enzyme activity.